Olema Pharmaceuticals, Inc. Common Stock (OLMA) is a publicly traded Healthcare sector company. As of November 5, 2026, OLMA trades at $7.36 with a market cap of $643.11M and a P/E ratio of -4.40. OLMA moved +2.72% today. Year to date, OLMA is -69.93%; over the trailing twelve months it is -7.96%. Its 52-week range spans $2.86 to $36.26. Analyst consensus is strong buy with an average price target of $33.17. Rallies surfaces OLMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for OLMA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $7.36 |
| Market Cap | $643.11M |
| P/E Ratio | -4.40 |
| EPS | $-1.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.26 |
| 52-Week Low | $2.86 |
| Volume | 427.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-162.45M |
| Gross Margin | 0.00% |
8 analysts cover OLMA: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $33.17.